Superworth

Herbalife price to free cash flow HLF

Market value divided by free cash flow over the last twelve months, since 2011.

Today, Oct 23, 2026
4.4×
10-year median
11.6×
Against its 10-year history
10th
percentile: 0 is its lowest day, 100 its highest
10-year range
3.0× to 41.9×
Peer median
16.4×

Herbalife's price to free cash flow is 4.4× as of Oct 23, 2026.

That is below its ten-year median of 11.6×, lower than on 90% of days in the last ten years.

Over that time it ranged from 3.0× in Feb 2025 to 41.9× in Oct 2017.

The median for 10 healthcare stocks of a similar size is 16.4×.

Price to free cash flow over time

The dashed line is the 10-year median and the shaded band the middle half of its days.

Open the interactive chart, with overlays and comparisons

Year by year

YearEnd of yearLowHigh
2026 so far4.4×3.2×8.2×
20256.3×3.0×7.0×
20243.7×3.5×7.7×
20238.8×7.2×13.5×
20226.5×5.5×14.6×
202113.2×10.2×15.5×
202011.1×10.6×20.9×
201921.2×13.7×21.5×
201814.8×13.6×20.3×
201714.0×13.5×41.9×
201617.8×8.9×20.3×
201510.7×6.2×15.0×
20147.8×7.0×14.0×
201313.4×8.3×13.8×
20127.4×6.9×20.1×
201114.3×14.3×22.3×

Against its peers

Companies in Healthcare nearest Herbalife's size, closest first, today.

CompanyPrice to free cash flow
HLFHerbalife4.4×
PCRXPacira BioSciences8.1×
ANABAnaptysbion/m
PNTGPennant42.2×
CNMDCONMED11.0×
EYENational Vision30.1×
USPHU S Physical Therapy20.6×
TRUPTrupanion15.7×
CDRECadre16.4×
BVSBioventus13.3×
PAHCPhibro Animal Health160×
Peer median16.4×

What the price to free cash flow tells you

Market value divided by free cash flow: the cash left after running the business and paying for equipment. Cash is harder to manage than accounting earnings, so many investors trust this more than PE.

Lumpy: a big year of building factories drops cash flow and inflates the ratio without the business getting worse.

More on Herbalife

Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.